Welcome to our dedicated page for Lichen International news (Ticker: LICN), a resource for investors and traders seeking the latest updates and insights on Lichen International stock.
Lichen International Limited, formerly Lichen China Limited, reports developments tied to its financial and taxation services business in China. The company provides financial and tax solution services, education support services, and software and maintenance offerings under the Lichen brand.
Recurring news themes include operating results, price competition in consulting services, AI-related product development for financial and tax applications, and the integration of Bondly Enterprises after Lichen acquired full ownership. Company updates also cover Nasdaq listing compliance, its reverse stock split and name change, shareholder approvals, material agreements, and other capital-structure actions involving its ordinary shares.
Lichen China (LICN) has announced a registered direct offering of 15,000,000 Class A ordinary shares at $0.18 per share, aiming to raise approximately $2.70 million in gross proceeds. The offering includes pre-funded warrants with an exercise price of $0.001 per share. The transaction is expected to close around December 13, 2024, with Univest Securities, serving as the sole placement agent. The offering is being conducted under a shelf registration statement on Form F-3 previously declared effective by the SEC on March 1, 2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Lichen China Limited announced the pricing of its initial public offering (IPO) of 4,000,000 Class A ordinary shares at $4.00 per share, generating $16 million in gross proceeds. The shares began trading on Nasdaq on February 6, 2023, under the ticker symbol LICN. The company plans to use the funds for expanding financial services, enhancing R&D capabilities, and improving brand recognition. Underwriters have a 45-day option to purchase an additional 600,000 shares. The registration statement for the offering was declared effective by the SEC on February 3, 2023.
Lichen China Limited (LICN) announced the pricing of its initial public offering (IPO) of 4,000,000 Class A ordinary shares at $4.00 per share, expected to raise $16 million in gross proceeds. The shares have been approved for listing on the Nasdaq Capital Market and trading is set to begin on February 6, 2023. The Company has also granted underwriters a 45-day option to purchase an additional 600,000 shares. Proceeds will be utilized for expanding financial services, enhancing research and development, improving brand recognition, and general corporate matters. The IPO is led by Univest Securities, LLC as underwriter.